Popular Trials
Platelet Rich Plasma Therapy
Autologous Conditioned Plasma (ACP) for Plantar Fasciitis
Plantar fasciitis presents clinically as pain in the inner heal, which is the result of degeneration of the plantar fascia, an arch supporting ligament of the foot. It manifests predominantly in those subjected to sustained weight bearing or repetitive pounding activities. Plantar fasciitis is the most common cause of inferior foot pain. Although most cases resolving within 6 months, traditional treatment regiments such as orthotics and physiotherapy are occasionally unsuccessful in treating this limitation leading to chronic symptoms (Neufeld \& Cerrato, 2008; Rompe, 2009; Roxas, 2005). Platelets are central players in clotting, inflammation and the wound healing response. Research has shown the potential of platelet rich plasma to accelerate wound healing in a variety of conditions including maxillo-fascial and plastic surgery, chronic wound healing and orthopaedics. Autologous Conditioned Plasma (ACP) is a novel treatment that may accelerate the healing of injured tissue. Treatment with ACP involves taking a blood sample from the patient, isolating the platelets and injecting them back into that patient at the injury site
Behavioural Intervention
Minimal Shoes and Exercises for Plantar Fasciitis
"This trial aims to see if foot exercises and minimal footwear can help older adults with foot pain. Participants will be split into two groups - one with minimal shoes and exercises, and the other with supportive shoes
Orthotics
3D-Printed Orthotics for Plantar Fasciitis
This trial tests a new method using 3D printing to make custom foot inserts for people with plantar fasciitis. It aims to see if these inserts work better than traditional ones and if patients are satisfied with them. 3D printed foot orthoses have been shown to be effective in treating various foot conditions, including plantar fasciitis, by improving foot biomechanics and comfort.
Popular Filters
Trials for Plantar Fibroma Patients
Neurotoxin
AbobotulinumtoxinA for Plantar Fibroma
The purpose of this research is to collect safety and efficacy data on injection of botulinumtoxinA (AbobotulinumtoxinA /Dysort) into the gastrocnemius (calf) muscle to improve equinus (lack of flexibility to bring the top of the foot towards the front of the leg) in subjects with plantar fasciitis and relieve pain associated with this condition. The use of AbobotulinumtoxinA is considered experimental in this study because it has not been approved by the United States Food and Drug Administration (FDA) for the treatment of plantar fasciitis.
Regenerative Injection Therapy
Regenerative injection therapy for Plantar Fibroma
The purpose of this study is to demonstrate that prolotherapy in conjunction with a physiotherapy program looking at reinforcing calf muscle and muscle of the plantar fascia, relieves pain and improves function of people suffering of plantar fasciitis, an inflammation of the plantar fascia, after basic treatment failure.
Neurotoxin
Botulinum Toxin vs. Corticosteroid for Plantar Fasciitis
This trial is testing Botox injections to treat patients with plantar fasciitis who haven't improved with other treatments. Botox may help by relaxing muscles and reducing swelling, which can relieve pain and improve movement. The study aims to see if Botox works better than standard steroid injections. Botox injections have shown significant pain relief and functional improvement in patients with plantar fasciitis.
Trials With No Placebo
Behavioural Intervention
Foot Rehab + Minimalist Shoes for Plantar Fasciitis
This trial will compare the effects of doing foot rehab exercises and wearing minimalist shoes to just doing foot rehab exercises for reducing pain, improving function, increasing muscle strength, and improving balance and gait.
Neurotoxin
AbobotulinumtoxinA for Plantar Fibroma
The purpose of this research is to collect safety and efficacy data on injection of botulinumtoxinA (AbobotulinumtoxinA /Dysort) into the gastrocnemius (calf) muscle to improve equinus (lack of flexibility to bring the top of the foot towards the front of the leg) in subjects with plantar fasciitis and relieve pain associated with this condition. The use of AbobotulinumtoxinA is considered experimental in this study because it has not been approved by the United States Food and Drug Administration (FDA) for the treatment of plantar fasciitis.
Procedure
Corticosteroid Injection +1 More for Plantar Fasciitis
This trial is testing a new injection called ReNuâ„¢ to see if it can help people with plantar fasciitis, a condition that causes foot pain and swelling. The study will compare ReNuâ„¢ to the usual treatment, which is a corticosteroid injection. Researchers will check how well each treatment works by asking patients about their pain and satisfaction over time.
Frequently Asked Questions
Introduction to plantar fasciitis
What are the top hospitals conducting plantar fasciitis research?
Plantar fasciitis, a common and often debilitating condition that affects the feet, is being actively addressed by top hospitals across the United States. In Winston-Salem, Wake Forest University Health Sciences takes the lead with their ongoing clinical trial dedicated to plantar fasciitis. This groundbreaking study marks their first recorded trial in 2023, showcasing their commitment to finding effective treatment options for this condition. Meanwhile, Madigan Army Medical Center in Tacoma is also making strides with an active plantar fasciitis trial and a history of one completed study since initiating their research efforts in 2022.
In Salt Lake City, the VA Salt Lake City Health Care System joins these pioneering institutions with an ongoing clinical trial targeting plantar fasciitis. Their dedication to understanding this condition began in 2022 and underscores their commitment to improving patient outcomes.
The UF Health Orthopaedics and Sports Medicine Institute located in Gainesville has similarly undertaken an active plantar fasciitis trial alongside its counterparts nationwide. With its inaugural investigation launched in 2022, they are helping pave the way toward potential breakthroughs for those suffering from this painful foot ailment.
Last but not least is New york's Hospital for Special Surgery which stands out within this group of esteemed hospitals. They have already made significant contributions through their comprehensive approach towards addressing plantar fasciitis. Having initiated a clinical trial as early as 2020 specifically tailored towards this condition, they continue to explore innovative treatments that may alleviate pain and improve quality of life for patients.
These progressive initiatives reflect how medical professionals are working tirelessly across multiple locations to tackle plantar fasciitis head-on while expanding our understanding of its causes and developing novel interventions that can provide hope for individuals grappling with this challenging foot disorder.
Which are the best cities for plantar fasciitis clinical trials?
When it comes to plantar fasciitis clinical trials, several cities show promising research opportunities. Tacoma, Washington leads the way with 2 active trials examining treatments like The Usual Care + PBM Group and Custom PFO orthosis. Winston-Salem, North carolina follows closely behind with 1 ongoing trial focused on corticosteroid injection/local anesthetic (CSI/LA). Salt Lake City, Utah and Gainesville, Florida also contribute to the advancement of knowledge in this field with 1 active trial each exploring Botulinum Toxin A and Control Cohort interventions respectively. Additionally, New york, New York joins the ranks with its own ongoing study investigating control methods for this condition. These cities offer individuals suffering from plantar fasciitis access to innovative clinical trials that may lead to improved treatment options and better outcomes.
Which are the top treatments for plantar fasciitis being explored in clinical trials?
Plantar fasciitis, a common condition causing heel pain, is the focus of ongoing clinical trials exploring potential treatments. Two notable contenders in these studies are Botulinum Toxin A and Control Cohort. Both have one active trial dedicated to plantar fasciitis and were first listed in 2022. As researchers delve deeper into their efficacy, they hold promise for providing relief to individuals suffering from this painful foot ailment.
What are the most recent clinical trials for plantar fasciitis?
Exciting progress is being made in the field of plantar fasciitis research, as recent clinical trials offer promising insights into its treatment. One notable trial explores the effectiveness of corticosteroid injection/local anesthetic (CSI/LA) for managing this condition. Another study focuses on Botulinum Toxin A and its potential therapeutic benefits, with phases 2 and 3 already completed. Additionally, a phase 2 trial examines AbobotulinumtoxinA 300 UNT as a possible treatment option. While these trials showcase advancements in plantar fasciitis management, it's important to note that regenerative injection therapy has been available since May 2011 but continues to be explored further through a phase 4 trial. These developments provide hope for individuals suffering from plantar fasciitis and pave the way for improved care strategies moving forward
What plantar fasciitis clinical trials were recently completed?
Recently completed clinical trials have shed light on the treatment of plantar fasciitis, a common and painful foot condition. These studies have provided valuable insights into potential therapeutic approaches for this ailment. Efforts led by prominent researchers and institutions have yielded noteworthy results in our quest to alleviate plantar fasciitis symptoms. Stay tuned for more comprehensive information regarding these groundbreaking trials as we strive to better understand and effectively address this debilitating condition affecting countless individuals worldwide.